El nuevo virus forma parte de los Sarbecovirus, que es un subgénero del Betacoronavirus a los que pertenecen los Coronavirus. El patógeno bautizado como Khosta-2 tiene la capacidad para entrar en las células humanas y podría ser resistente a las vacunas actuales. La investigación científica sobre el hallazgo fue publicada […]
To say that Krystal Lashley went to great lengths to get the Novavax COVID-19 vaccine (NVX-CoV2373) would be a gross understatement. In April, Lashley traveled roughly 3700 miles from her home in Metuchen, New Jersey, to a pharmacy in Paris, France, for her first dose. She then flew to the […]
Un virus recientemente descubierto en un murciélago ruso y similar al SARS-CoV-2 es capaz de entrar en las células humanas y sería resistente a las vacunas, pero carece de algunos de los genes que se cree que están implicados en la patogénesis en humanos. El virus se ha llamado Khosta-2 y es un sarbecovirus, la misma subcategoría que el […]
In a recent study published in Indoor Air, researchers extensively searched for the origins of the resistance to recognizing airborne transmission during the coronavirus disease 2019 (COVID-19) pandemic by major public health organizations, including the World Health Organization (WHO) and the United States Centers of Disease Control and Prevention (US-CDC). Background […]
Question What are the 2-year health outcomes among patients hospitalized for COVID-19 in China? Findings In this longitudinal cohort study that included 1864 patients, the most common symptoms at 2 years after SARS-CoV-2 infection were fatigue, chest tightness, anxiety, dyspnea, and myalgia, and most symptoms resolved from 1-year to 2-year follow-up, although […]
Clinicians should test for parechovirus in young infants with fever, sepsis-like symptoms, or meningitis without another known cause, according to a July 12 CDC health advisory sparked by reports of the illness in several states. Most children have been exposed to parechovirus by kindergarten. Symptoms may vary depending on the strain and […]
Researchers used a recently developed method of wastewater genomic surveillance to detect SARS-CoV-2 infections on the University of California, San Diego (UCSD), campus during 10 months of the pandemic. The approach identified viral variants of concern as early as 2 weeks before the variants showed up in clinical tests, the […]
Researchers have identified an antibody that broadly neutralized all tested SARS-CoV-2 subvariants as well as SARS-CoV-1 in laboratory experiments and several SARS-CoV-2 variants of concern in mice. Because it targets a spike protein area that may be less affected by genetic variations, the newly discovered antibody could better retain potency against emerging […]
ACKGROUND The Ad26.COV2.S vaccine is a recombinant, replication-incompetent human adenovirus type 26 vector encoding full-length severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein in a prefusion-stabilized conformation. METHODS In an international, randomized, double-blind, placebo-controlled, phase 3 trial, we randomly assigned adult participants in a 1:1 ratio to receive a […]
Summary What is already known about this topic? Monkeypox virus (MPXV) typically causes a febrile illness with lymphadenopathy and a diffuse vesiculopustular rash; neurologic complications are rare. The current monkeypox outbreak differs clinically and epidemiologically from previous outbreaks, and little is known about potential associated neurologic complications. What is added by […]
